EXPERIENCE WITH COMBINATION TREATMENT FOR GENITAL HERPES IN WOMEN


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

Objective. To analyze the clinical efficacy of lavomax in combination therapy for genital herpes (GH) with emphasis on its impact on the body’s nonspecific resistance. Subjects and methods. Forty-nine women with GH were followed up. Its diagnosis was verified by enzyme immunoassay and polymerase chain reaction. Results. Immunological studies revealed impairments in the phagocytic component of immunity. The findings suggest that lavomax used in the combination therapy of GH is pathogenetically grounded and effective. Conclusion. Combination therapy using lavomax has a normalizing impact on the body’s natural resistance and rapidly eliminates the clinical manifestations of herpesvirus infection, and achieves a stable clinical resolution.

全文:

受限制的访问

作者简介

V. UDZHUKHU

Russian National Research Medical University, Federal Agency for Health Care and Social Development

Email: ail.: sovet140011@mail.ru
Department of Dermatovenereology, Faculty of Pediatrics

参考

  1. Адаскевич В. П. Инфекции, передаваемые половым путем // Руководство для врачей. Н. Новгород: Медицинская книга, Изд-во Нижегородской государственной медицинской академии, 2004.
  2. Буданов П.В. Проблемы терапии рецидивирующего генитального герпеса // Вопросы гинекологии, акушерствас и перинатологии. — 2004. — Т. 3, № 4. — С. 94—98.
  3. Hollier L.M., Straub H. Genital herpes //. Clin Evid (Online). — 2011. — Р. 1603.
  4. Field H.J., Biswas S. Antiviral drug resistance and helicaseprimase inhibitors of herpes simplex virus // Drug. Resist. Updat. — 2011. — Т. 14. № 1. — Р. 45—51.
  5. Sauerbrei A., Deinhardt S., Zell R. et all. Testing of herpes simplex virus for resistance to antiviral drugs // Virulence. — 2010. — Т. 1, № 6. — Р. 55—57.

补充文件

附件文件
动作
1. JATS XML

版权所有 © Bionika Media, 2011
##common.cookie##